AgrawalAK, DasS, TirthalliJ. Clonazepam in catatonia: Thinking beyond the boundary of lorazepam: A case report. Indian J Psychol Med, 2023; 45(1):97–99; doi: 10.1177/02537176221116265
2.
BenarousX, RaffinM, FerrafiatV, et al. Catatonia in children and adolescents: New perspectives. Schizophr Res, 2018; 200:56–67; doi: 10.1016/j.schres.2017.07.028
3.
BoazakM, CotesRO, PotvinH, et al. Catatonia due to clozapine withdrawal: A case report and literature review. Psychosomatics, 2019; 60(4):421–427; doi: 10.1016/j.psym.2018.07.010
4.
EdinoffAN, KaufmanSE, HollierJW, et al. Catatonia: Clinical overview of the diagnosis, treatment, and clinical challenges. Neurol Int, 2021; 13(4):570–586; doi: 10.3390/neurolint13040057
5.
ElhassanienAF, AlghaiatyHA. Joubert syndrome: Clinical and radiological characteristics of nine patients. Ann Indian Acad Neurol, 2013; 16(2):239–244; doi: 10.4103/0972-2327.112480
6.
EllulP, ChouchaW. Neurobiological approach of catatonia and treatment perspectives. Front Psychiatry, 2015; 6:182; doi: 10.3389/fpsyt.2015.00182
7.
GanaS, SerpieriV, ValenteEM. Genotype-phenotype correlates in Joubert syndrome: A review. Am J Med Genet C Semin Med Genet, 2022; 190(1):72–88; doi: 10.1002/ajmg.c.31963
8.
GriffinCE3rd, KayeAM, BuenoFR, et al. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J, 2013; 13(2):214–223.
9.
HickeyCL, ShermanJC, GoldenbergP, et al. Cerebellar cognitive affective syndrome: Insights from Joubert syndrome. Cerebellum Ataxias, 2018; 5:5; doi: 10.1186/s40673-018-0085-y
10.
MariaBL, BoltshauserE, PalmerSC, et al. Clinical features and revised diagnostic criteria in Joubert syndrome. J Child Neurol, 1999; 14(9):583–591; doi: 10.1177/088307389901400906
11.
NedostupAV, FedorovaVI, DmitrievKV. Labile hypertension in elderly: Clinical features, autonomic regulation of circulation, approaches to treatment. Klin Med (Mosk.), 2000; 78(7):27–32.
12.
NovacAA, BotaD, WitkowskiJ, et al. Special medical conditions associated with catatonia in the internal medicine setting: Hyponatremia-inducing psychosis and subsequent catatonia. Perm J, 2014; 18(3):78–81; doi: 10.7812/TPP/13-143
13.
RaffinM, Zugaj-BensaouL, BodeauN, et al. Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry, 2015; 24(4):441–449; doi: 10.1007/s00787-014-0595-y
14.
SharmaCM, JenaS, SharmaD, et al. Role of lorazepam challenge test in childhood catatonia. J Pediatr Neurosci, 2014; 9(3):301–303; doi: 10.4103/1817-1745.147611
15.
SienaertP, DhosscheDM, VancampfortD, et al. A clinical review of the treatment of catatonia. Front Psychiatry, 2014; 5:181; doi: 10.3389/fpsyt.2014.00181
16.
TulenJH, MulderG, PepplinkhuizenL, et al. Effects of lorazepam on cardiac vagal tone during rest and mental stress; assessment by means of spectral analysis. Psychopharamcology (Berl), 1994; 114(1):81–89; doi: 10.1007/BF02245447
17.
WachtelLE, CrawfordTO, DhosscheDM, et al. Electroconvulsive therapy for pediatric malignant catatonia with cerebellar dysgenesis. Pediatr Neurol, 2010; 43(6):427–430; doi: 10.1016/j.pediatrneurol.2010.06.009
